Search Results

Delanzomib 2 mg  | 99.46%

TargetMol

CEP-18770 is an orally active inhibitor of the chymotrypsin-like activity of proteasome (IC50: 3.8 nM). It only marginally inhibits the tryptic and peptidylglutamyl activities of the proteosome.

More Information Supplier Page

Delanzomib 25 mg  | 99.46%

TargetMol

CEP-18770 is an orally active inhibitor of the chymotrypsin-like activity of proteasome (IC50: 3.8 nM). It only marginally inhibits the tryptic and peptidylglutamyl activities of the proteosome.

More Information Supplier Page

Delanzomib 10 mg  | 99.46%

TargetMol

CEP-18770 is an orally active inhibitor of the chymotrypsin-like activity of proteasome (IC50: 3.8 nM). It only marginally inhibits the tryptic and peptidylglutamyl activities of the proteosome.

More Information Supplier Page